GeneDx Holdings Corp. - Equity Warrant
US ˙ NasdaqGS ˙ US81663L1199

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Katherine Stueland. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Katherine Stueland har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:WGS / GeneDx Holdings Corp. CHIEF EXECUTIVE OFFICER, Director 14.578
US:NVTA / Invitae Corporation Chief Commercial Officer 214.231
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Katherine Stueland. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb WGSWW / GeneDx Holdings Corp. - Equity Warrant – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i WGSWW / GeneDx Holdings Corp. - Equity Warrant. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2022-11-28 SMFR Stueland Katherine 185.185 0,5400 185.185 0,5400 100.000 0 0.4597 -14.869 -14,87

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

WGSWW / GeneDx Holdings Corp. - Equity Warrant Insider Trades
Insidersalg WGSWW / GeneDx Holdings Corp. - Equity Warrant – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i WGSWW / GeneDx Holdings Corp. - Equity Warrant. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2025-09-16 WGS Stueland Katherine 10.501 121,4727 10.501 121,4727 1.275.585 0 121.3700 -1.078 -0,08
2025-09-09 WGS Stueland Katherine 3.639 128,0500 3.639 128,0500 465.974
2025-09-09 WGS Stueland Katherine 18 129,0790 18 129,0790 2.323
2025-07-29 WGS Stueland Katherine 2.154 105,3100 2.154 105,3100 226.838
2025-06-16 WGS Stueland Katherine 10.501 64,7730 10.501 64,7730 680.181
2025-06-09 WGS Stueland Katherine 3.639 72,5500 3.639 72,5500 264.009
2025-04-29 WGS Stueland Katherine 2.154 113,0900 2.154 113,0900 243.596
2025-03-26 WGS Stueland Katherine 44.801 95,6577 44.801 95,6577 4.285.561
2025-03-26 WGS Stueland Katherine 1.750 94,5850 1.750 94,5850 165.524
2025-03-17 WGS Stueland Katherine 10.559 96,7086 10.559 96,7086 1.021.146
2025-03-13 WGS Stueland Katherine 1.078 89,4437 1.078 89,4437 96.420
2025-03-10 WGS Stueland Katherine 2.731 94,7254 2.731 94,7254 258.695
2025-01-29 WGS Stueland Katherine 1.657 78,4828 1.657 78,4828 130.046
2024-12-16 WGS Stueland Katherine 10.501 76,7541 10.501 76,7541 805.995
2024-12-09 WGS Stueland Katherine 3.661 76,3719 3.661 76,3719 279.598
2024-10-29 WGS Stueland Katherine 2.154 66,6000 2.154 66,6000 143.456
2024-09-16 WGS Stueland Katherine 10.501 37,5900 10.501 37,5900 394.733
2024-09-09 WGS Stueland Katherine 3.639 33,3300 3.639 33,3300 121.288
2024-07-29 WGS Stueland Katherine 2.154 33,5400 2.154 33,5400 72.245
2024-06-17 WGS Stueland Katherine 7.683 28,3100 7.683 28,3100 217.506
2024-06-10 WGS Stueland Katherine 2.652 24,9200 2.652 24,9200 66.088
2024-04-29 WGS Stueland Katherine 6.325 11,0368 6.325 11,0368 69.808
2024-03-18 WGS Stueland Katherine 8.559 10,5925 8.559 10,5925 90.661
2024-03-12 WGS Stueland Katherine 2.618 9,2097 2.618 9,2097 24.111
2023-12-18 WGS Stueland Katherine 11.734 2,1594 11.734 2,1594 25.338
2023-12-11 WGS Stueland Katherine 3.673 1,6104 3.673 1,6104 5.915
2023-09-18 WGS Stueland Katherine 10.752 4,1619 10.752 4,1619 44.749
2023-09-11 WGS Stueland Katherine 2.675 4,6240 2.675 4,6240 12.369
2023-06-20 WGS Stueland Katherine 7.654 6,3703 7.654 6,3703 48.758
2023-06-20 WGS Stueland Katherine 311 6,3300 311 6,3300 1.969
2023-06-12 WGS Stueland Katherine 2.674 6,4898 2.674 6,4898 17.354
2023-05-16 WGS Stueland Katherine 8.685 6,4985 8.685 6,4985 56.439
2023-03-10 WGS Stueland Katherine 92.644 0,3598 2.807 11,8734 33.333

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

WGSWW / GeneDx Holdings Corp. - Equity Warrant Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Katherine Stueland som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-09-18 2025-09-16 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -10.501 14.578 -41,87 121,47 -1.275.585 1.770.829
2025-09-18 2025-09-16 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 18.750 25.079 296,26
2025-09-11 2025-09-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -18 6.329 -0,28 129,08 -2.323 816.941
2025-09-11 2025-09-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -3.639 6.347 -36,44 128,05 -465.974 812.733
2025-09-11 2025-09-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 6.546 9.986 190,29
2025-07-31 2025-07-29 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -2.154 3.440 -38,51 105,31 -226.838 362.266
2025-07-31 2025-07-29 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 3.874 5.594 225,23
2025-07-11 2025-07-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -3.220 1.720 -65,18 93,00 -299.460 159.960
2025-07-03 2025-07-01 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -135 4.940 -2,66 92,46 -12.482 456.757
2025-07-03 2025-07-01 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -2.594 5.075 -33,82 91,55 -237.483 464.621
2025-07-03 2025-07-01 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -6.928 7.669 -47,46 90,68 -628.215 695.407
2025-06-18 2025-06-16 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -10.501 14.597 -41,84 64,77 -680.181 945.491
2025-06-18 2025-06-16 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 18.750 25.098 295,37
2025-06-11 2025-06-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -3.639 6.348 -36,44 72,55 -264.009 460.547
2025-06-11 2025-06-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 6.547 9.987 190,32
2025-05-01 2025-04-29 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -2.154 3.440 -38,51 113,09 -243.596 389.030
2025-05-01 2025-04-29 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 3.874 5.594 225,23
2025-04-10 2025-04-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -705 1.720 -29,07 97,24 -68.557 167.260
2025-04-10 2025-04-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -3.174 2.425 -56,69 96,29 -305.637 233.512
2025-04-10 2025-04-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -3.173 5.599 -36,17 95,51 -303.053 534.759
2025-04-10 2025-04-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -4.511 8.772 -33,96 94,55 -426.517 829.396
2025-04-10 2025-04-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -9.628 13.283 -42,02 93,33 -898.558 1.239.671
2025-04-10 2025-04-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -1.000 22.911 -4,18 92,28 -92.280 2.114.227
2025-04-10 2025-04-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -1.900 23.911 -7,36 91,27 -173.420 2.182.445
2025-04-10 2025-04-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -1.600 25.811 -5,84 90,13 -144.207 2.326.335
2025-04-10 2025-04-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -300 27.411 -1,08 88,70 -26.609 2.431.265
2025-04-10 2025-04-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -373 27.711 -1,33 87,30 -32.563 2.419.184
2025-04-10 2025-04-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -5.855 28.084 -17,25 86,34 -505.549 2.424.907
2025-04-10 2025-04-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -3.175 33.939 -8,55 85,44 -271.262 2.899.643
2025-04-10 2025-04-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -2.745 37.114 -6,89 84,28 -231.348 3.127.960
2025-04-10 2025-04-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -3.297 39.859 -7,64 83,25 -274.486 3.318.389
2025-04-10 2025-04-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -3.134 43.156 -6,77 82,17 -257.509 3.545.960
2025-04-10 2025-04-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -2.024 46.290 -4,19 81,16 -164.262 3.756.771
2025-03-28 2025-03-26 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -1.750 48.314 -3,50 94,58 -165.524 4.569.780
2025-03-28 2025-03-26 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -44.801 50.064 -47,23 95,66 -4.285.561 4.789.007
2025-03-28 2025-03-26 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 80.000 94.865 538,18
2025-03-17 2025-03-17 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -10.559 14.865 -41,53 96,71 -1.021.146 1.437.573
2025-03-17 2025-03-16 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 18.750 25.424 280,94
2025-03-17 2025-03-13 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -1.078 6.674 -13,91 89,44 -96.420 596.947
2025-03-11 2025-03-10 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -2.731 7.752 -26,05 94,73 -258.695 734.311
2025-03-11 2025-03-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 6.546 10.483 166,27
2025-01-31 2025-01-29 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -1.657 3.937 -29,62 78,48 -130.046 308.987
2025-01-31 2025-01-29 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 3.874 5.594 225,23
2025-01-10 2025-01-07 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -10.005 1.720 -85,33 96,39 -964.359 165.787
2025-01-10 2025-01-07 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -9.176 11.725 -43,90 95,50 -876.282 1.119.705
2025-01-10 2025-01-07 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -8.439 20.901 -28,76 94,33 -796.036 1.971.554
2025-01-10 2025-01-07 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -23.800 29.340 -44,79 93,34 -2.221.442 2.738.534
2025-01-06 2025-01-02 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -1.564 53.140 -2,86 80,47 -125.860 4.276.356
2025-01-06 2025-01-02 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -4.242 54.704 -7,20 79,68 -337.991 4.358.662
2025-01-06 2025-01-02 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -4.078 58.946 -6,47 78,58 -320.433 4.631.741
2025-01-06 2025-01-02 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -3.417 63.024 -5,14 77,88 -266.120 4.908.378
2025-01-06 2025-01-02 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -2.051 66.441 -2,99 76,54 -156.976 5.085.148
2025-01-06 2025-01-02 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -2.654 68.492 -3,73 75,47 -200.307 5.169.331
2024-12-18 2024-12-16 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -10.501 71.146 -12,86 76,75 -805.995 5.460.747
2024-12-18 2024-12-16 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 18.750 81.647 29,81
2024-12-11 2024-12-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -3.661 62.897 -5,50 76,37 -279.598 4.803.563
2024-12-11 2024-12-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 6.547 66.558 10,91
2024-11-19 2024-11-18 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -3.131 60.011 -4,96 71,83 -224.905 4.310.698
2024-11-19 2024-11-18 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -8.580 63.142 -11,96 70,91 -608.418 4.477.475
2024-11-19 2024-11-18 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -6.186 71.722 -7,94 70,15 -433.952 5.031.349
2024-11-19 2024-11-18 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -3.151 77.908 -3,89 68,98 -217.349 5.373.930
2024-11-19 2024-11-18 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -459 81.059 -0,56 67,94 -31.183 5.506.857
2024-11-19 2024-11-18 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -800 81.518 -0,97 66,60 -53.283 5.429.409
2024-11-19 2024-11-15 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -60 82.318 -0,07 74,34 -4.460 6.119.430
2024-11-19 2024-11-15 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -1.510 82.378 -1,80 73,71 -111.302 6.072.074
2024-11-19 2024-11-15 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -2.043 83.888 -2,38 72,95 -149.045 6.119.948
2024-11-19 2024-11-15 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -1.958 85.931 -2,23 71,49 -139.977 6.143.181
2024-11-19 2024-11-15 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -7.240 87.889 -7,61 70,72 -511.985 6.215.167
2024-11-19 2024-11-15 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -4.800 95.129 -4,80 69,67 -334.439 6.628.094
2024-11-19 2024-11-15 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale X -5.497 99.929 -5,21 68,65 -377.386 6.860.436
2024-10-31 2024-10-29 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -2.154 105.426 -2,00 66,60 -143.456 7.021.372
2024-10-31 2024-10-29 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 3.874 107.580 3,74
2024-09-18 2024-09-16 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -10.501 103.706 -9,19 37,59 -394.733 3.898.309
2024-09-18 2024-09-16 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 18.750 114.207 19,64
2024-09-11 2024-09-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -3.639 95.457 -3,67 33,33 -121.288 3.181.582
2024-09-11 2024-09-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 6.546 99.096 7,07
2024-07-31 2024-07-29 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -2.154 92.550 -2,27 33,54 -72.245 3.104.127
2024-07-31 2024-07-29 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 3.874 94.704 4,27
2024-06-18 2024-06-17 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -7.683 90.830 -7,80 28,31 -217.506 2.571.397
2024-06-18 2024-06-16 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 18.750 98.513 23,51
2024-06-11 2024-06-10 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -2.652 79.763 -3,22 24,92 -66.088 1.987.694
2024-06-11 2024-06-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 6.546 82.415 8,63
2024-04-30 2024-04-29 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -6.325 75.869 -7,70 11,04 -69.808 837.351
2024-04-30 2024-04-29 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 15.496 82.194 23,23
2024-03-19 2024-03-18 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -8.559 66.698 -11,37 10,59 -90.661 706.499
2024-03-19 2024-03-16 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 18.750 75.257 33,18
2024-03-13 2024-03-12 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -2.618 56.507 -4,43 9,21 -24.111 520.413
2024-03-12 2024-03-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 6.547 59.125 12,45
2023-12-19 2023-12-18 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -11.734 52.578 -18,25 2,16 -25.338 113.537
2023-12-19 2023-12-16 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 18.750 64.312 41,15
2023-12-12 2023-12-11 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -3.673 45.562 -7,46 1,61 -5.915 73.373
2023-12-12 2023-12-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 6.546 49.235 15,33
2023-09-19 2023-09-18 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -10.752 42.689 -20,12 4,16 -44.749 177.667
2023-09-19 2023-09-16 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 18.750 53.441 54,05
2023-09-12 2023-09-11 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -2.675 34.691 -7,16 4,62 -12.369 160.411
2023-09-12 2023-09-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 6.547 37.366 21,24
2023-06-21 2023-06-20 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -311 30.819 -1,00 6,33 -1.969 195.084
2023-06-21 2023-06-20 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -7.654 31.130 -19,73 6,37 -48.758 198.307
2023-06-21 2023-06-16 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 18.750 38.784 93,59
2023-06-13 2023-06-12 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -2.674 20.034 -11,78 6,49 -17.354 130.017
2023-06-13 2023-06-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 6.546 22.708 40,50
2023-05-18 2023-05-16 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -8.685 16.162 -34,95 6,50 -56.439 105.029
2023-05-02 2023-04-29 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise -511.364 819.938 -38,41
2023-03-13 2023-03-10 4 WGS GeneDx Holdings Corp.
Class A Common Stock
S - Sale -92.644 308.574 -23,09 0,36 -33.333 111.025
2023-03-13 2023-03-09 4 WGS GeneDx Holdings Corp.
Class A Common Stock
M - Exercise 216.033 401.218 116,66
2022-11-28 2022-11-28 4 SMFR Sema4 Holdings Corp.
Class A Common Stock
P - Purchase 185.185 185.185 0,54 100.000 100.000
2022-05-06 2022-05-02 4/A SMFR Sema4 Holdings Corp.
Employee Stock Option
A - Award 3.551.136 3.551.136
2022-05-04 2022-05-02 4 SMFR Sema4 Holdings Corp.
Restricted Stock Unit
A - Award 2.045.454 2.045.454
2022-05-04 2022-05-02 4 SMFR Sema4 Holdings Corp.
Employee Stock Option (Right to Buy)
A - Award 3.551.136 3.551.136
2021-06-16 2021-06-14 4 NVTA Invitae Corp
Common Stock
S - Sale -8.834 214.231 -3,96 31,63 -279.376 6.775.077
2021-06-16 2021-06-14 4 NVTA Invitae Corp
Common Stock
S - Sale X -11.506 223.065 -4,91 31,58 -363.303 7.043.300
2021-05-04 2021-04-30 4 NVTA Invitae Corp
Employee Stock Option (right to buy)
A - Award 23.200 23.200
2021-05-04 2021-04-30 4 NVTA Invitae Corp
Common Stock
A - Award 44.700 234.571 23,54
2021-04-15 2021-04-14 4 NVTA Invitae Corp
Common Stock
S - Sale X -100 189.871 -0,05 41,02 -4.102 7.788.508
2021-04-15 2021-04-14 4 NVTA Invitae Corp
Common Stock
S - Sale X -9.799 189.971 -4,91 40,37 -395.581 7.669.034
2021-04-15 2021-04-14 4 NVTA Invitae Corp
Common Stock
S - Sale X -9.994 199.770 -4,76 39,38 -393.527 7.866.203
2021-03-19 2021-03-15 4/A NVTA Invitae Corp
Common Stock
S - Sale -5.781 209.764 -2,68 42,90 -248.008 8.999.001
2021-03-17 2021-03-15 4 NVTA Invitae Corp
Common Stock
A - Award -5.781 209.764 -2,68 42,90 -248.008 8.999.001
2021-03-17 2021-03-15 4 NVTA Invitae Corp
Common Stock
S - Sale -12.443 215.545 -5,46 42,90 -533.812 9.247.010
2021-03-17 2021-03-12 4 NVTA Invitae Corp
Common Stock
A - Award 24.936 227.988 12,28
2021-02-26 2021-02-25 4 NVTA Invitae Corp
Employee Stock Options (Right to Buy)
M - Exercise -5.000 35.000 -12,50
2021-02-26 2021-02-25 4 NVTA Invitae Corp
Common Stock
S - Sale X -300 203.052 -0,15 41,75 -12.524 8.476.751
2021-02-26 2021-02-25 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.300 203.352 -0,64 40,97 -53.260 8.331.169
2021-02-26 2021-02-25 4 NVTA Invitae Corp
Common Stock
S - Sale X -2.300 204.652 -1,11 39,65 -91.196 8.114.534
2021-02-26 2021-02-25 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.100 206.952 -0,53 38,95 -42.844 8.060.594
2021-02-26 2021-02-25 4 NVTA Invitae Corp
Common Stock
M - Exercise 5.000 208.052 2,46 10,23 51.150 2.128.372
2021-01-15 2021-01-13 4 NVTA Invitae Corp
Employee Stock Options (Right to Buy)
M - Exercise -4.199 25.801 -14,00
2021-01-15 2021-01-13 4 NVTA Invitae Corp
Common Stock
S - Sale X -400 203.052 -0,20 53,22 -21.290 10.807.443
2021-01-15 2021-01-13 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.600 203.452 -0,78 52,71 -84.330 10.723.182
2021-01-15 2021-01-13 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.567 205.052 -0,76 51,55 -80.777 10.570.226
2021-01-15 2021-01-13 4 NVTA Invitae Corp
Common Stock
S - Sale X -400 206.619 -0,19 49,88 -19.951 10.305.639
2021-01-15 2021-01-13 4 NVTA Invitae Corp
Common Stock
S - Sale X -232 207.019 -0,11 48,50 -11.251 10.039.738
2021-01-15 2021-01-13 4 NVTA Invitae Corp
Common Stock
M - Exercise 4.199 207.251 2,07 10,94 45.937 2.267.326
2020-12-16 2020-12-14 4 NVTA Invitae Corp
Common Stock
S - Sale X -4.646 203.052 -2,24 61,06 -283.685 12.398.355
2020-12-16 2020-12-14 4 NVTA Invitae Corp
Common Stock
S - Sale X -10.341 207.698 -4,74 60,33 -623.873 12.530.420
2020-12-16 2020-12-14 4 NVTA Invitae Corp
Common Stock
S - Sale X -2.801 218.039 -1,27 59,45 -166.519 12.962.419
2020-12-16 2020-12-14 4 NVTA Invitae Corp
Common Stock
S - Sale X -5.900 220.840 -2,60 57,85 -341.315 12.775.594
2020-12-16 2020-12-14 4 NVTA Invitae Corp
Common Stock
S - Sale X -2.717 226.740 -1,18 56,84 -154.434 12.887.902
2020-12-16 2020-12-14 4 NVTA Invitae Corp
Common Stock
S - Sale X -3.100 229.457 -1,33 55,67 -172.577 12.773.871
2020-12-16 2020-12-14 4 NVTA Invitae Corp
Common Stock
S - Sale X -4.795 232.557 -2,02 54,57 -261.663 12.690.635
2020-11-16 2020-11-13 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.000 237.352 -0,42 48,00 -48.000 11.392.896
2020-10-15 2020-10-13 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.000 238.352 -0,42 51,36 -51.360 12.241.759
2020-09-16 2020-09-15 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.000 239.352 -0,42 35,51 -35.510 8.499.390
2020-09-14 2020-09-10 4 NVTA Invitae Corp
Common Stock
S - Sale -631 240.352 -0,26 33,87 -21.370 8.139.905
2020-09-04 2020-09-03 4 NVTA Invitae Corp
Common Stock
A - Award 1.253 240.983 0,52
2020-08-20 2020-08-19 4 NVTA Invitae Corp
Common Stock
S - Sale -21.345 239.730 -8,18 32,10 -685.102 7.694.518
2020-08-13 2020-08-12 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.000 261.075 -0,38 29,31 -29.310 7.652.108
2020-07-16 2020-07-14 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.000 262.075 -0,38 32,50 -32.500 8.517.438
2020-06-16 2020-06-12 4 NVTA Invitae Corp
Employee Stock Option (right to buy)
A - Award 19.600 19.600
2020-06-16 2020-06-12 4 NVTA Invitae Corp
Common Stock
A - Award 59.150 263.075 29,01
2020-06-16 2020-06-12 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.000 203.925 -0,49 16,34 -16.340 3.332.134
2020-05-22 2020-05-20 4 NVTA Invitae Corp
Common Stock
S - Sale -6.177 204.925 -2,93 16,70 -103.161 3.422.411
2020-05-14 2020-05-13 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.000 211.102 -0,47 17,56 -17.560 3.706.951
2020-04-14 2020-04-13 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.000 212.102 -0,47 12,80 -12.803 2.715.542
2020-03-16 2020-03-16 4 NVTA Invitae Corp
Common Stock
S - Sale -10.684 213.102 -4,77 11,79 -125.964 2.512.473
2020-03-16 2020-03-13 4 NVTA Invitae Corp
Common Stock
S - Sale X -65 223.786 -0,03 12,60 -819 2.819.704
2020-03-16 2020-03-13 4 NVTA Invitae Corp
Common Stock
S - Sale X -935 223.851 -0,42 11,58 -10.825 2.591.635
2020-03-16 2020-03-12 4 NVTA Invitae Corp
Common Stock
A - Award 91.733 224.786 68,94
2020-03-02 2020-02-27 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.000 133.053 -0,75 20,44 -20.435 2.718.938
2020-01-15 2020-01-14 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.000 134.053 -0,74 18,14 -18.137 2.431.373
2019-12-16 2019-12-13 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.000 135.053 -0,74 17,08 -17.082 2.306.962
2019-11-15 2019-11-14 4 NVTA Invitae Corp
Common Stock
S - Sale X -3.788 136.053 -2,71 17,46 -66.123 2.374.928
2019-09-18 2019-09-17 4 NVTA Invitae Corp
Common Stock
S - Sale X -3.788 139.841 -2,64 21,40 -81.081 2.993.255
2019-08-21 2019-08-19 4 NVTA Invitae Corp
Common Stock
S - Sale -22.900 143.629 -13,75 25,29 -579.239 3.632.995
2019-08-19 2019-08-16 4 NVTA Invitae Corp
Common Stock
S - Sale X -3.789 166.529 -2,22 24,98 -94.645 4.159.695
2019-07-16 2019-07-15 4 NVTA Invitae Corp
Common Stock
S - Sale X -3.789 170.318 -2,18 22,49 -85.231 3.831.184
2019-06-14 2019-06-13 4 NVTA Invitae Corp
Common Stock
S - Sale X -3.789 174.107 -2,13 19,36 -73.356 3.370.746
2019-05-22 2019-05-20 4 NVTA Invitae Corp
Common Stock
S - Sale -6.474 177.896 -3,51 18,21 -117.892 3.239.486
2019-05-17 2019-05-15 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.000 184.370 -0,54 18,36 -18.360 3.385.033
2019-04-17 2019-04-16 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.000 185.370 -0,54 25,23 -25.230 4.676.885
2019-03-19 2019-03-15 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.000 186.370 -0,53 23,49 -23.490 4.377.831
2019-03-01 2019-02-27 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.000 187.370 -0,53 19,61 -19.610 3.674.326
2019-01-16 2019-01-15 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.000 188.370 -0,53 13,59 -13.590 2.559.948
2018-12-19 2018-12-17 4 NVTA Invitae Corp
Common Stock
S - Sale X -1.000 189.370 -0,53 11,44 -11.437 2.165.825
2018-11-16 2018-11-15 4 NVTA Invitae Corp
Common Stock
F - Taxes X -1.593 190.370 -0,83 12,66 -20.173 2.410.731
2018-09-11 2018-09-09 4 NVTA Invitae Corp
Common Stock
S - Sale -595 191.963 -0,31 13,62 -8.104 2.614.536
2018-06-25 2018-06-22 4 NVTA Invitae Corp
Common Stock
A - Award 140.000 192.558 266,37
2018-05-16 2018-05-15 4 NVTA Invitae Corp
Common Stock
S - Sale -6.012 52.558 -10,26 6,96 -41.844 365.804
2017-09-14 2017-09-12 4 NVTA Invitae Corp
Common Stock
S - Sale -612 58.570 -1,03 9,40 -5.753 550.558
2017-02-15 2017-02-15 4 NVTA Invitae Corp
Common Stock
S - Sale -911 59.182 -1,52 9,50 -8.655 562.276
2017-02-15 2017-02-13 4 NVTA Invitae Corp
Common Stock
A - Award 2.152 60.093 3,71
2017-02-07 2017-02-03 4 NVTA Invitae Corp
Common Stock
A - Award 52.941 57.941 1.058,82
2016-11-14 3 NVTA Invitae Corp
Common Stock
10.000
2016-11-14 3 NVTA Invitae Corp
Common Stock
10.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)